poster

Assessment of the deutetrabenazine exposure-response relationships for patients with moderate-to-severe tardive dyskinesia

Abstract: Background: Deutetrabenazine (Teva) is indicated for chorea associated with Huntington’s disease and tardive dyskinesia (TD). Individual optimization of treatment based on effi...

01/19/2023

Efficacy, Safety and Tolerability of Brexpiprazole for the Treatment of Agitation in Alzheimer’s Dementia: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Abstract: Background: Agitation is common in Alzheimer’s dementia, and one of the most stressful aspects of care. The aim of this study was to confirm the efficacy, safety and tolerabilit...

01/19/2023

Abstract: Introduction: Major depressive disorder (MDD) is associated with humanistic and economic burden. Little is known about this burden among those with treatment failure. This analy...

01/19/2023

Assessing Treatment Patterns and Economic Impact of Atypical Antipsychotics as the First Adjunctive Treatment for MDD

Abstract: Introduction: Patients with major depressive disorder (MDD) often cycle through multiple treatments prior to receiving an adjunctive atypical antipsychotic (AA). This study eval...

01/19/2023

Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Illness: Results of the ENLIGHTEN-Early Study

Abstract: Aims: This 12-week, phase 3, multicenter, double-blind study (NCT03187769) evaluated the effect of combination olanzapine and samidorphan (OLZ/SAM) vs olanzapine on weight in ea...

01/19/2023

Changes in QIDS-SR16 scores during the COVID-19 pandemic by age group

Abstract: Introduction: The Coronavirus-19 (COVID-19) pandemic represented an unprecedented challenge to the mental health of the global population. The purpose of this study was to deter...

01/19/2023

A 16-Week Open-Label Study of the Effects of Treatment With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis (PDP)

Abstract: Introduction: Accurate assessment of disability associated with Parkinson’s Disease Psychosis (PDP) is essential and has been poorly studied. Patients often have poor insight on...

01/19/2023

Preliminary evaluation of the impact of olanzapine/samidorphan on weight change in patients with schizophrenia or bipolar 1 disorder in a private practice setting.

Abstract: Objective: The prevalence of obesity and associated metabolic disorders in patients with schizophrenia or bipolar 1 disorder is approximately 60%. These comorbidities contribute...

01/19/2023

Characteristics and Treatment of Adult Patients With Post-Traumatic Stress Disorder – A Retrospective Claims-Based Analysis

Abstract: Background: Despite available guidelines, identifying and managing post-traumatic stress disorder (PTSD) in clinical practice remains challenging due to the heterogenous disease...

01/19/2023

Estimating Changes in Weight and Metabolic Parameters Before and After Treatment With Cariprazine: A Retrospective Study of Electronic Health Records

Abstract: Introduction: Effects of cariprazine on weight and metabolic parameters were evaluated. Methods: Analyses based on Optum Humedica electronic health records data from October 1,...

01/19/2023

Tracks

Major Depressive Disorder

General Psychiatry

ADHD

MDD Insights

Schizophrenia Insights

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.

December 9 ⁠–⁠ December 11

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

May 28 ⁠–⁠ May 31

See Full Calendar

poster

Tracks

About

Specialties

Events

Year Round Education

HMP Global Products